Neurotransmission of the antidepressant-like effects of the growth hormone-releasing hormone antagonist MZ-4-71

Behavioural Brain Research

Volumn 228, Issue 2, 2012, Pages 388-391

  Tanaka, M ^a   Schally, A V ^b   Telegdy, G ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Depression; GH RH antagonist; MZ 4 71; Receptor interactions

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADRENERGIC RECEPTOR; AMYLOID BETA PROTEIN[25-35]; ATROPINE; BICUCULLINE; CHOLINERGIC RECEPTOR; CYPROHEPTADINE; DOPAMINE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; HALOPERIDOL; HORMONE ANTAGONIST; ISOBUTYRYL DEXTRO ARGINYL 2 PARA CHLOROPHENYLALANYL 6 ALPHA AMINOBUTYRYL 15 NORLEUCYL 27; METHYSERGIDE; MUSCARINIC RECEPTOR; MZ 471; PHENOXYBENZAMINE; PRAZOSIN; PROPRANOLOL; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN FUNCTION; CLIMBING; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; FORCED SWIMMING TEST; HORMONE RELEASE; IMMOBILIZATION; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NEUROTRANSMISSION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GROWTH HORMONE-RELEASING HORMONE; IMMOBILITY RESPONSE, TONIC; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MUSCLE STRENGTH; NEUROTRANSMITTER AGENTS; SERMORELIN; SWIMMING;

EID: 84862776770     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.12.022     Document Type: Article

References (18)

1. Gola M., Doga M., Bonadonna S., Mazziotti G., Vescovi P.P., Giustina A. Neuroendocrine tumors secreting growth hormone-releasing hormone: pathophysiological and clinical aspects. Pituitary 2006, 9(3):221-229.
2. Schally A.V., Varga J.L., Engel J.B. Antagonists of growth hormone-releasing hormone: an emerging new therapy for cancer. Nat Clin Endocrinol Metab 2008, 4:33-43.
3. Zarandi M., Horvath J.E., Halmos G., Pinski J., Nagy A., Groot K., Rekasi Z., Schally A.V. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci USA 1994, 91(25):12298-12302.
4. Telegdy G., Tanaka M., Schally A.V. Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice. Behav Brain Res. 2011, 224(1):155-158.
5. Pellergrino A.S., Cushman A.J. Stereotaxic Atlas of the Rat Brain 1979, Plenum Press, New York, pp. 8-57.
6. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and nor adrenergic antidepressants. Psychopharmacology (Berl) 1995, 121(1):66-72.
7. Khisti R.T., Chopde C.T., Jain S.P. Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 2000, 67(1):137-143.
8. Consoli D., Leggio G.M., Mazzola C., Micale V., Drago F.F. Behavioral effects of the beta 3 adrenoceptor agonist SR 58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?. Eur J Pharmacol 2007, 573(1-3):139-147.
9. Dhingra D., Sharma A. Antidepressant-like activity of n-hexane extract of nutmeg (Myristica fragrans) seeds in mice. J Med Food 2006, 9(1):84-89.
10. Dhir A., Kulkarni S.K. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test. Pharmacology 2007, 80(4):239-243.
11. Dias Elpo Zomkowski A., Oscar Rosa A., Lin J., Santos A.R., Calixto J.B., Lúcia Severo Rodrigues A. Evidence for seroton in receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res. 2004, 1023(2):253-263.
12. Evangelista S., Borsini F., Meli A. Evidence that muscimol acts in the forced swimming test by activating the rat dopaminergic system. Life Sci. 1987, 41(24):2679-2684.
13. Reny-Palasse V., Rips R. Potentiation by TRH of the effect of imipramine on the forced-swimming test. Br J Pharmacol 1985, 85(2):463-470.
14. Kovacs M., Kineman R.D., Schally A.V., Zarándi M., Groot K., Frohman L.A. Effects of antagonists of growth hormone-releasing hormone (GH-RH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GH-RH gene, an animal model of acromegaly. Endocrinology 1997, 138:4536-4542.
15. Banks W.A., Morley J.E., Farr S.A., Price T.O., Ercal N., Vidaurre I., Schally A.V. Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity and aging in mice. Proc Natl Acad Sci USA 2010, 107:22272-22277. [Early edition].
16. Barabutis N., Schally A.V. Growth hormone-releasing hormone. Extrapituitary effects in physiology and pharmacology. Cell Cycle 2010, 9(20):4110-4116.
17. Telegdy G., Tiricz H., Adamik A. Involvement of neurotransmitters in urocortin-induced passive avoidance learning in mice. Brain Res Bull 2005, 67:242-247.
18. Jaeger L.B., Banks W.A., Varga J., Schally A.V. Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumor. Proc Natl Acad Sci USA 2005, 102:12495-12500.